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Abstract 
Surgical site infections (SSis) are a subset of a larger group of infections that are 
known as hospital acquired infections (HAis). SSis are a huge financial burden, costing 
billions of dollars in excess hospital charges every year. There is a considerable amount 
of evidence-based practice recommendations that can help reduce the incidence of SSis. 
Research has supported the efficacy of preoperative antibiotic prophylaxis when 
appropriately selected and timed according to published guidelines. In addition to these 
measures, re-dosing of antibiotics must occur for those procedures that last more than 
four hours in order to continue to maintain tissue perfusion throughout the surgical 
procedure. The purpose of this study was to evaluate the timely administration, 
appropriate selection, and dosage of preoperative prophylactic antibiotics in surgical 
patients in one community hospital. A retrospective research design was used to obtain 
information on 100 randomly selected colon, hysterectomy, total hip and knee 
arthroplasty cases. Data were collected on those surgical procedures that occurred 
between October 1, 2010 and March 31 , 2011. During this time period, there were eight 
documented SSis, three involving an organ space, and five that were superficial. In more 
than half of the colon and hysterectomy cases, the prophylactic antibiotic was 
administered less than 30 minutes before surgical incision, and in more than half of the 
total hip and total knee arthroplasty cases, antibiotic administration was between 30-60 
minutes. All the procedures met the SCIP recommendations for timing and selection of 
prophylactic antibiotic. This study suggests that to ensure adequate tissue perfusion prior 
to surgical incision, the antibiotic should be administered in the preoperative holding unit, 
ill 
immediately prior to transfer to the operating room. This would assure that the antibiotic 
is given 30-60 minute timeframe, thus reducing the potential for the development of a 
SSI. Recommendations for further research and advanced nursing practice are discussed. 
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Statement of the Problem 
A surgical site infection (SSI) is an unexpected event that adversely affects a patient, 
complicates the postoperative course, and results in a poor outcome (Fry & Fry, 2007). 
SSis are the second most common health care-associated infection (HAl) and result in 
increased length of hospital stay, readmissions, significant costs, and mortality. Among 
surgical patients, SSis are the most common nosocomial infection, accounting for 38% of 
the total number (Barnett, 2007 ). According to Anderson et al. (2008), there are more 
than 30 million surgical procedures performed annually in the United States (US). Of 
those, 2-5% will develop a SSI, or one out of every 24 patients who have inpatient 
surgery. With shortened hospital stays and an increase in ambulatory surgical centers, 
the incidence of SSis is on the rise (Anderson , Harris, & Sexton, 2011 ). 
Edmiston et al. (2008) reported that the probability of a patient developing a 
postoperative SSI is influenced by selected intrinsic, patient-related risk factors and 
extrinsic, procedure-related risk factors. Anderson et al. (2011) described the various 
patient-related risk factors that may contribute to the development of a SSI. Risks factors 
are separated into patient-related (preoperative), procedure-related (perioperative), and 
post operative categories (Table 1 ). These risk factors can either be modifiable or 
unmodifiable. An example of an unmodifiable risk factor is age; the most common and 
modifiable risk factor would be poorly controlled diabetes (Anderson et al.). 
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Table 1 
Risk Factors for Surgical Site Infections and Current Recommendations to Decrease the 
Risk of 
a Surgical Site Infection 
Risk Factors I Recommendations 
Intrinsic or patient related 
(Preoperative) 
Age No formal recommendation or relationship to increased risk of 
SSI. 
May be secondary to patient co-morbidities 
Glucose control, Control of serum blood glucose levels 
Diabetes mellitus 
Obesity Increased dosing of peri operative antibiotic for morbid 
Smoking Cessation Encourage smoking cessation within 30 days of surgical 
procedure 
Immunosuppressive medications No formal recommendation 
Nutrition 2 colors 
Remote sites of infection Identity and ~ all infections before surgery 
Preoperative hospitalization Keep preoperative stay short 
Extrinsic or procedure-related 
(Perioperative) 
Preparation ofthe patient 
Hair removal Do not remove unless there is hair that will interfere with the 
surgical procedure. Hair should be clipped, not shaved and as 
close to the time of surgery as possible 
Skin ·Preparation Wash and clean skin around the incision site. Use an approved 
skin preparation 
CWorhexidine nasal and oropharyngeal rinse No formal recommendation 
Surgical scrub(surgeon's hands and forearms Use appropriate antiseptic agent. Perform 2-5 minute 
preoperative skin scrub 
Incision site Use appropriate skin antiseptic agent 
Antibiotic prophylaxis Administer only when indicated 
Timing Administer within one hour of surgical incision. This time is 
considered optimal for tissue and serum perfusion 
Choice Select appropriate antibiotic based on the type of surgery and 
published guidelines 
Duration of therapy Stop antibiotic within 24 hours after the surgical procedure 
Surgeon skills/technique Handle tissue carefuJly and eradicate dead space 
incision time No formal recommendation 
Maintain oxygenation with supplemental 02 No formal recommendation 
Maintain normothermia A void hypothermia in surgical patients. Actively warm the 
patient to > 36°C especially in colorectal surgery 
OR characteristics 
Ventilation Follow the American Institute of Architects recommendations 
Traffic Minimize traffic in the Operating Room 
Environmental surfaces Use and EPA-approved hospital disinfectant to clean visibly 
soiled or contaminated surfaces and equipment 
(Anderson et al. , 2011) 
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The timely administration, selection, and dosage of appropriate preoperative 
prophylactic antibiotics is an important element in the prevention of a SSI. According to 
Zaidi, Tariq, and Breslin (2009), perioperative administration of antibiotics has 
demonstrated efficacy in reducing the risk of a SSI. The Centers for Medicare & 
Medicaid Services (CMS), in collaboration with the Centers for Disease Control and 
Prevention (CDC), implemented the Surgical Care Improvement Project (SCIP) in the 
hope of decreasing morbidity and mortality that is so often associated with postoperative 
SSis. Based on SCIP's current evidence based guidelines, antibiotics should be 
administered within 60 minutes of the surgical incision, and within 120 minutes for the 
administration of vancomycin and fluoroquinolones (Bratzler & Hunt, 2006). The 
appropriate timing of the antibiotic should attain optimal tissue and serum drug levels and 
then be maintained throughout the surgical procedure (Meeks et al. , 2011). The selection 
of the antibiotic should be based on the procedure and the published evidence-based 
recommendations (Anderson et al., 2008). To encourage appropropriate antibiotic 
prophylaxis, the CDC, CMS, and The Joint Commission (TJC) have adopted 
performance measures that specify the choice, timing, and duration of prophylactic 
antibiotics. Organizations are expected to adhere to these measures, and facility 
compliance is now publicly reported on a government website that can be found at 
http:///www.hospitalcompare.hhs.gov (Steinburg et al., 2009). Despite the high-quality 
evidence to support preventative guidelines and improve patient outcomes, compliance 
with the guidelines is suboptimal in many hospitals, usually due to patient, provider, and 
system level factors (Meeks et al., 2011). With the movement toward public reporting of 
4 
quality performance measures and fmancial incentives such as pay-for perfomance, 
noncompliance with SCIP guidelines can have significant consequences for healthcare 
organizations (Bratzler & Hunt, 2006). 
The purpose of this study was to evaluate the timely administration, appropriate 
selection, and dosage of preoperative prophylactic antibiotics and the impact in the 
prevention of surgical site infections. 
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Review of the Literature 
A literature review was conducted using the following databases and websites: 
Cumulative Index to Nursing and Allied Health Literature (CINAHL); Mosby's Nursing 
Skills; Pub Med; Up-to-Date; CDC; CMS; and TJC. Keywords used included: 
preoperative prophylactic antibiotics, surgical site infection, health care acquired 
infection, surgical wound classification, antibiotic selection, timing of antibiotic, repeat 
dosing of antibiotics, obesity and antibiotic prophylaxis, and the Surgical Care 
Improvement Project (SCIP). 
SSI Definition and Impact 
Historically, surgical complications were thought to be inevitable. Development of a 
SSI was predictable, simply a risk of the surgical business. It is now estimated that as 
many as 60% of SSis are preventable, mostly related to the use of recommended 
evidence-based practices such as the timing, selection, and duration of preoperative 
prophylactic antibiotics (Meeks et al., 2011 ). According to Fry and Fry (2007), a SSI is 
an unexpected event that adversely affects a patient, complicates the postoperative 
course, and results in a poor outcome. Owens and Stoessel (2008) defined a SSI as an 
infection that has occurred within 30 days of an operative procedure or within one year if 
an implant has been left in place. These infections may be superficial, deep incisional or 
involve an organ or body space. SSis are still a major cause of morbidity and mortality in 
spite of all the improvements in infection control techniques and in surgical practice 
(Owens & Stoessel). 
6 
Bucher, Warner, and Dillon (2011) completed a review of the literature that 
examined SSis and prophylactic antibiotics. The purpose of their review was to 
highlight the progress that has been occurring with regard to the understanding of SSis 
and to identifY the current role of antimicrobial prophylaxis in the prevention of a SSI. 
The authors discussed some original studies that mainly focused on procedural risk 
factors for developing a SSI. For example, they refer to the CDC wound classification 
system that is still widely used today. This classification system is based on predicting 
the degree of bacterial contamination by identifYing those procedures in which the 
likelihood of developing a SSI exists. For a SSI to occur, microbial contamination of 
the surgical wound must occur at the time of surgery. For many patients the 
comtarnination occurs from endogenous flora either from the skin or exposed hollow 
viscus. Exogenous floral contamination of a surgical wound can transfer from 
operating room personnel, equipment, implants, or the medication that is administered 
during the procedure. There are few organisms to blame for many of the SSis. Gram-
positive organisms are largely responsible for the majority of SSis in class I wounds. 
In class II and III wounds, endogenous Gram-negative organisms contributed to SSis 
when a hollow visus is entered. The emergence of resistant organisms that are isolated 
from the surgical wound is becoming a major concern with regards to the development 
of a SSI. In particular methicillin-resistant staph aureus (MRSA) and the percentage 
of infections attributed to MRSA has dramatically increased. It has been found that 
MRSA accounts for 23% of all Gram-positive isolates and 20% of all SSI isolates. 
Also patients with MRSA attributed SSis had longer hospital stays, increased cost of 
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care, and higher mortality rates. The authors go on to say that currently the CDC does 
not recommend routine antibiotic prophylaxis to cover MRSA except in certain 
clinical circumstances. It depends on the type and location of the MRS A. 
Antimicrobial prophylaxis is an attempt to reduce the risk of a SSI by timing the 
administration of an antibiotic to match the potential intra-operative wound 
contamination. Antibiotic prophylaxis is recommended for all procedures with a high 
SSI risk (class II and III), or any procedure which poses a high risk for the 
development of a SSI. The use of an antimicrobial prophylaxis is not recommended 
by the CDC if there are no additional risk factors. There are three principles with 
regards to the use antimicrobial prophylaxis: the agent must cover the pathogens 
specific to the planned surgical procedure, administration of an antimicrobial to 
establish bactericidal tissue levels must occur prior to incision, and continued 
administration of an antimicrobial should last no longer than 24-48 hours after the 
procedure has been completed. The timing of antimicrobial prophylaxis is critical to 
its efficacy. In procedures where the administration of the antibiotic occurred within 2 
hours of incision, the risk of a SSI was greatly reduced compared with an antibiotic 
administered earlier than 2 hours. There is no evidence to support the continuation of 
an antimicrobial beyond 24 hours after the procedure. The continuation of an 
antimicrobial for longer durations may actually increase the risk of developing a 
resistant organism. The authors concluded that patients, surgeons, and hospitals have 
a vested interest in preventing SSis and that several decades of data have demonstrated 
the ability of antibiotic prophylaxis to significantly reduce the risk of an SSI. 
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There is considerable cost associated with the development of a SSI. The expense 
varies widely depending on the severity of the infection and treatment course. Barnett 
(2007) reported that each SSI causes an additional 7-10 postoperative hospital days. 
Depending on the type of infection and infecting pathogen, the cost of treating a SSI 
ranges from $3 ,000-$29,000 and adds up to $10 billion annually (Barnett); the cost 
when due to a resistant organism is likely even higher (Anderson et al. , 2011 ). Most 
estimates are based on inpatient costs and do not account for the additional costs of 
rehospitalization, post-discharge outpatient expenses, and any long term disabilities 
(Barnett, 2007). SSis pose a substantial clinical burden (Owens & Stoessel, 2008). 
Kirkland, Briggs, Trivette, Wilkinson, and Sexton (1999) studied 215 matched 
pairs of patients with a SSI and those without. The relative risk for death associated 
with a SSI was 2.2%, while the relative risk for readmission and ICU treatment were 
5.5%. Patients who developed a SSI required longer hospitalization: the mean 
duration was 11 days for the infected patient versus six days for the uninfected patient. 
The mean extra hospital duration was 6.5 days, and in a SSI involving organs or body 
space, there was even a longer hospital duration and increased costs compared with a 
SSI that only involved the incision or was superficial in nature. 
Morbidity and mortality is associated with SSis. Patients that develop a SSI are up 
to 60% more likely to spend time in the Intensive Care Unit (ICU), where care is 
costly for both the patient and hospital (Barnett, 2007). The patient with a SSI is five 
times more likely to be readmitted to the hospital (Fry & Fry, 2007), and 77% of 
deaths among patients with a SSI are directly attributable to the SSI. Potentially 
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preventable complications are estimated to add 9.4%-9.7% to hospital inpatient costs 
(Fuller, McCullough, Bao, & Averill, 2009). 
Evidence Based Guidelines and Initiatives for Prevention of SSis 
CMS created the Surgical Infection Prevention Collaborative (SIP) (Anderson et al., 
2008) in 2002 to identify performance measures for quality improvement related to 
antibiotic prophylaxis. SIP recommendations include prophylactic antibiotic within one 
hour of surgical incision (two hours for vancomycin and :fluoroquinolones), and the 
antibiotic selected must be on the published guidelines and discontinued within 24 hours 
after surgery. The SIP collaborative focused on seven procedures: abdominal 
hysterectomy; vaginal hysterectomy; hip arthoplasty; knee arthroplasty; cardiac;vascular; 
and colorectal. Those hospitals that implemented and improved compliance with SIP 
performance measures saw their SSI rates go down. 
The Surgical Care Improvement Project (SCIP), an extension of SIP, was started in 
2005 in an attempt to significantly reduce the incidence of surgical complications through 
collaborative efforts. SCIP continues to assess the performance measures of SIP and also 
provides evidence based information about the prevention of complications. SCIP 
became a national quality partnership that was created in collaboration with CMS and the 
CDC, along with representatives of the Veterans Administration (VA), the American 
College of Surgeons (ACS), the American Society of Anesthesiologist (ASA), the 
Agency for Healthcare Research and Quality (AHRQ), the American Hospital 
Association (AHA), and The Institute for Healthcare Improvement (IHI) (Bratzler & 
Hunt, 2006). This partnership focused on reducing the incidence and cost of 
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complications in surgery. Recommendations included the proper use of antibiotics as 
defmed by the SCIP measures (Appendix A). This project has led to a reduction in 
surgical complications as a result of healthcare professionals' attitudes toward surgery 
(Clancy, 2008). CMS estimates that compliance with the SCIP measures will help 
prevent up to 13,027 perioperative deaths and 271 ,055 surgical complications annually 
for Medicare patients alone (Bratzler & Hunt, 2006). 
On the federal government level, healthcare organizations must meet SCIP 
requirements in order to be reimbursed for services rendered. Anderson et al. (2008) 
described the creation of the Deficit Reduction Act in 2005 that requires acute care 
hospitals that are paid by Medicare to submit quality measure information to CMS as a 
requirement for reimbursement. This requirement allows CMS to adjust payments 
downward for those patients that develop a HAL CMS now requires inclusion of 
prophylactic antibiotics within one hour of surgery and antibiotics to be discontinued 
within 24 hours after surgery as a quality measure for payment. 
Research Regarding Evidence Based Strategies 
In 1999, the Infection Control Advisory Committee that is part of the CDC published 
guidelines that outlined the principles of prophylactic antibiotic administration for 
surgical practice. The guidelines include: identification of procedures that would benefit 
from prophylactic antibiotics; drug of choice for selected procedures; recommended 
timing of the antibiotics; duration of use; and discontinuing antibiotics. Another tool that 
perioperative practitioners can use that addresses data collection and analysis related to 
SSI prevention is the Specifications Manual for National Hospital Inpatient Quality 
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Measures (Appendix B). These guidelines represents a collaborative effort between 
CMS and TJC, and provide algorithms that outline prophylactic antibiotic administration 
as well as the correct antibiotic for particular procedures (Wanzer, Goeckner, and Hicks , 
2011). 
Accurate and timely administration of antibiotics is a critical element in perioperative 
care (Wanzer et al. , 2011), and the most important factors in the prevention ofSSis are 
meticulous aseptic technique and the timely administration of selected preoperative 
antibiotics (Anderson et al. , 2011). The goal of antibiotic prophylaxis is to prevent a SSI 
by reducing the microorganisms at the surgical site during the operative procedure. The 
efficacy of antibiotic prophylaxis for reducing a SSI has been clearly established 
(Anderson et al.). Patients who receive prophylactic antibiotics within one hour to two 
hours before surgical incision have lower rates of SSI than those patients who receive 
antibiotics closer to the time of incision. However, errors in selection or dose of 
prophylactic antibiotics are common. Among 34,133 patients undergoing surgery in 
centers around the US, an antibiotic administered within one hour of the incision 
occurred in only 56% of patients (Anderson et al.) 
Timing, Selection and Dosage 
Classen et al. (1992) conducted a prospective observational study of2,847 patients 
that underwent elective clean or clean contaminated procedures at a large community 
hospital. Of the 1708 patients who received the prophylactic antibiotic preoperatively, or 
two hours before surgical incision, only 10 developed a SSI. In 282 patients that 
received the antibiotic perioperatively, or three hours after surgical incision, only four 
12 
developed a SSI (p = .12) compared with the perioperatively treated group. Of 488 
patients who received an antibiotic postoperatively, more than three hours but less than 
24 hours after surgical incision, 16 patients developed a wound infection (p < .0001). 
Lastly, patients that had the antibiotic administered early, 2-24 hours before surgery, 14 
developed an infection (p < .0001). The investigators noted that this analysis confirmed 
their suspicions that the administration of an antibiotic in the perioperative period was 
associated with a lower risk of the patient developing a SSI. They concluded that the 
administration of prophylactic antibiotics is significantly varied in institutions, but 
administration of antibiotics two hours prior to surgical incison will reduce the 
probability of developing a SSI. 
Zanetti, Giardina, & Platt (2001) conducted a retrospective study that compared the 
risk of SSI in 1 ,548 patients having cardiac surgery that lasted more than four hours. The 
researchers also examined the possible value of intraoperative redo sing for extended 
surgical procedures. These patients received cefazolin preoperatively and then 30% 
received a repeat dose intraoperatively. The overall risk of a SSI was similar among the 
patients with (n = 43[9.4%] of 459) and without (n = 101 [9.3%] of 1089) of 
intraoperative dosing. Redosing was beneficial in those procedures that lasted greater 
than 4 hours. Infections occurred in 7.7% (n = 14) of patients with redosing and in 16% 
(n = 32) of patients without. Intraoperative redosing of cefazolin was associated with a 
16% reduction in the overall risk of developing a SSI in cardiac surgery and included 
those procedures that lasted greater than 240 minutes. 
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Edmiston, Kelly, Larson, Andris, & Hennen (2004) conducted a study with the 
bariatric patient population to assess serum and tissue levels resulting from 
administration of a 2 gram (gm) dose of cefazolin. The primary purpose of the study was 
to determine if peri operative antibiotic prophylaxis provided therapeutic and effective 
drug concentrations in tissue prior to the surgical incision, intraoperatively, and after skin 
closure. Patients undergoing Roux-en-Y gastric bypass for morbid obesity were treated 
prophylactically with a 2 gm dose of cefazolin preoperatively. They were then followed 
by a second dose of antibiotics at three hours. There were 38 patients and each was 
assigned to one of three body mass index (BMI) groups: A group (n = 17) with a BMI 
40-49; B group (n = 11) with a BMI 50-59; and group C (n = 10) with a BMI greater 
than 60. There were multiple, timed serum levels obtained at baseline, during surgical 
incision, and at 15, 30, and 60 minutes prior to the administration of the second dose of 
prophylactic antibiotic. Tissue that included skin, subcutaneous fat, and omentum was 
also collected and analyzed by microbiological assay to determine the cefazolin 
concentrations. The analysis revealed that over 90% of the serum samples had 
therapeutic levels that covered 53.8% of gram positive and 76.6% of gram negative 
surgical pathogens. Therapeutic tissue levels were achieved in only 48.1 %, 28.6%, and 
10.2% of groups A, B, and C. The investigators concluded that less than 29% of the 
tissue samples had enough of a cefazolin concentration to inhibit either staphylococcus 
aureus or staphylococcus epidermidis in the surgical wound. The fmdings of this study 
suggested that a 2gm dose of an antibiotic prophylaxis is suboptimal in those patients 
with a BMI greater than 40. The investigators suggested that surgical practitioners 
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consider increasing the prophylactic dose of antibiotic in elective surgery for those 
patients with a high BMI. 
Weber et al. (2008) conducted a prospective observational cohort study that examined 
the incidence of SSI and the timing of antibiotic prophylaxis in 3,836 consecutive 
surgical procedures. The purpose of this study was to obtain accurate information on the 
optimal timeframe for administration of surgical prophylactic antibiotics. The 
researchers reported that although perioperative antimicrobial prophylaxis is a well 
known approach for reducing the risk of a SSI, the optimal timing for administration of 
an antibiotic has not been precisely determined. Consecutive surgeries conducted 
between January 1, 2000 and December 31,2001 that were performed in the Visceral, 
Vascular, and Tramatology Divisions of the General Surgery Department at Basel 
University Hospital in Basel, Switzerland were included in this study. Excluded 
procedures included those that: did not have an incision; had a hospital stay of less than 
24 hours; had a wound classification of dirty-infected; were procedures in which 
antibiotics were administered for more than 24 hours after surgical incision; did not 
comply with the hospital guidelines for administration of prophylactic antibiotic within 2 
hours before skin incision. Surgical wounds and any resulting infection were assessed 
using CDC standards. A total of 82 variables were examined, including but not limited to 
age, sex, underlying disease, additional diagnoses, American Society of Anesthesiologists 
(ASA) score, type of surgery, surgical team members, wound class, duration of surgery, 
length of hospital stay, and intensive care before and after the surgery. The methods used 
for postdischarge monitoring of the patient included: 30 days for non-implant and one 
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year for implant surgery. Any case that showed evidence of a SSI was validated by a 
board certified infectious disease specialist. Antimicrobial prophylaxis was administered 
by the anesthesia team and included a single dose of intravenous (IV) infusion of 1.5 gm 
of cefuroxime in 20 milliters (ml) of sodiun chloride over 2-5 minutes. This antibiotic 
was combined with metronidazole (500 milligrams (mg), IV, over 5 minutes) in 
colorectal patients; for patients with renal failure, the dosage was adjusted based on 
creatinine clearance. Colorectal patients received no intralumimal antibiotics but did 
complete a bowel preparation. The data was divided into time intervals of 30-60 minutes 
and 0-29 minutes before skin incision. Overall the SSI rate was 4.7% ( n = 3836). In 
49% of all the procedures, an antimicrobial prophylaxis was administered within the half 
an hour prior to the start of the procedure. Multi variable logistic regression analyses was 
able to demonstrate an increase in the odds of a SSI when antimicrobial prophylaxis was 
administered less than 30 minutes (p < .001) and 60-120 minutes (p = .035) as compared 
to 30-59 minutes before incision is made. The researchers concluded that the risk of 
developing a SSI is reduced when cefuroxime is used as a prophylactic antibiotic and 
given 30-59 minutes before the surgical incision is made. 
Nelson, Glenny, and Song (2008) conducted a systematic review published by The 
Cochrane Colloborative. They examined randomized controlled trials (RCTs) published 
between January 1980 and December 2007 to assess the effectiveness of antimicrobial 
prophylaxis in the prevention of a surgical wound infection (SWI) in elective and 
emergency colorectal surgery. The goal ofthis systematic review was to look at the 
principles of antibiotic administration. The investigators looked at the timing of 
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antibiotic administration, duration, route, and the bacterial coverage needed in an 
antibiotic for the prevention of a SWI in elective colorectal surgery. This review 
included 182 RCTs (30,880 patients) and a total of 50 different antibiotics, with 17 that 
included cephalosporins, thought to be the antibiotic that contributes to Clostridium 
difficile colitis (C-diff) infection. This type of procedure was selected due to the fact that 
the abdominal wound has the greatest risk of infection, most commonly from colorectal 
bacteria contamination. Ten trials (813 patients) were published between 1980 and 1996 
that compared administration of some type of prophylactic antibiotic with that of no 
treatment as the control/placebo. The overall result of these trials showed that their was 
"significant benefit" (p < .00001) in favor of antibiotic prophylaxis with a variety of 
antibiotics. Twenty-five trials (n = 3589) published between 1984 and 2000 looked at 
short term versus long term use of an antimicrobial either alone or in combination with 
another antimicrobial agent. These trials were studied in several different formats and the 
researchers concluded that there was no advantage with longer dosing of an antimicrobial 
(p = 0.51 ). It was recommended that for those antibiotics with a shorter half life, a 
second dose should be given for longer surgical procedures. Eleven trials (1269 patients) 
studied antimicrobial prophyaxis treatment with additional aerobic coverage versus the 
same antimicrobial treatment with no additional aerobic coverage. These trials 
demonstrated that if a patient received an antibiotic that covered anaerobic bacteria, and 
an antibiotic that covers aerobic bacteria is added, there is a considerable reduction in the 
incidence of a SWI, though not significant (p = .17). Fifteen trials (2394 patients) that 
were published between 1980 and 1992 examined antimicrobial prophylaxis treatment 
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with no other aerobic coverage compared to the same treatment without extra anaerobic 
coverage. These trials demonstrated that the addition of an antibiotic with anaerobic 
coverage to an antibiotic with aerobic coverage resulted in a reduction in the 
development of a SWI (p = .008). There was just one RCT (n = 72) ) that compared the 
effectiveness of kanamycin and metronidazole when given by different routes of 
administration. In this study there was no significant difference in SWI rates. Thirteen 
reports (N = 2362 ) examined a combination of oral and intravenous (IV) antimicrobial 
prophylaxis compared to only IV antimicrobials. The results indicated that combining 
both oral and IV antibiotics was beneficial compared to IV alone with regards to 
antibiotic prophylaxis (p < .0001). Three studies (N = 283) studied antibiotic 
prophylaxis that was given both orally and IV and compared to the oral route only. 
These trials demonstrated a considerable benefit for the combination of oral and IV 
dosed antibiotics compared to only oral doses of prophylactic antibiotics (p = .02). 
Twenty-eight trials (N = 3077) studied administration of various types of prophylactic 
antibiotic. The analysis compared any type of antibiotic with those antibiotics regarded 
as the "gold standard" in antimicrobial treatment: oral neomycin, erythromycin, IV 
cefoxitin or cefotetan, and IV doxycycline. The purpose of this analysis was to detect 
statistical significance from the existing data with regard to those antibiotics deemed as 
gold standard antibiotics. One trial compared IV ceftriaxone and metronidazole to oral 
neomycin and erthromycin with substantial benefit however, other ceftriaxone studies did 
not show a benefit in the prevention of a SWI when this antibiotic was compared to other 
IV choices. There was an additional trial that resulted in considerable benefit with both 
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oral and IV doses of two gold standard drugs, IV cefoxitin and oral 
neomycin/erythromycin. These drugs were found to be more effective in combination 
versus using each alone however, the results of this trial were inconclusive. 
From this meta-analysis, Nelson et al. concluded that antibiotic prophylaxis is 
essential for patients having colorectal surgery. The potential exposure of the operative 
field to comtarninated colonic contents is enough to warrant the use of prophylactic 
antibiotics. An IV antibiotic must be administered before surgery with the best time 
being one hour before surgical incision however, the investigators acknowledge that 
determination of the optimal timing of prophylactic antibiotics is currently lacking 
evidence. The analysis found no need for re-dosing postoperatively, and the antibiotics 
selected for prophylaxis must cover both aerobic and anaerobic bacteria. 
In what was probably the largest multicentered prospective study related to this topic, 
Steinburg et al. (2009) examined the relationship between antibiotic timing and SSI risk. 
The Trial to Reduce Antimicrobial Prophylaxis Errors (TRAPE) Study Group aimed to 
determine the optimal timing for surgical antibiotic prophylaxis. This group believed that 
national antibiotic guidelines should be well supported by evidence and this could only 
be obtained from large data sets. Twenty nine hospitals prospectively obtained 
information on antibiotic prophylaxis from 4,472 randomly selected cardiac, hip 
arthroplasty, knee arthroplasty, and hysterectomy cases. Only cephalosporins or other 
antibiotics that were designated by SCIP guidelines were administered. In the study, 
3,405 patients received antibiotic within 60 minutes of incision; 575 patients received 
cephalosporins and vancomycin; 218 received vancomycin only; 240 received 
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fluorquinolones with or without other agents; and 34 had no documented antiobiotic 
prophylaxis. The antibiotic selection met SCIP indicators in 90% of the cases. All 
TRAPE participating hospitals then measured antibiotic prophylaxis performance in 100 
randomly selected surgical cases in two, six month periods from June to November 2003 
(baseline) and February to July 2005 (re-measurement). The authors found that 113 SSis 
occurred in 1 09 patients (four patients with multiple infections), and that the risk of an 
SSI increased as the interval of time between antibiotic infusion and the surgical incision 
increased. In 1 ,062 cases, the surgical procedure lasted greater than four hours, and only 
21% of the patients received intraoperative redosing. The data supported that redosing 
appears to reduce the incidence of SSI risk for those procedures lasting more than four 
hours, but only when the preoperative dose was given correctly. This study was of major 
importance as it found a consistent relationship between antibiotic prophylaxis timing 
and infection risk. There was a lower risk when cephalosporins and other antibiotics with 
short infusion times were given 30 minutes prior to surgical incision (p = 0.04). The 
authors noted that compliance with SCIP measures ultimately reduced the risk of 
infection. However, they stated that organizations should improve compliance with 
intraoperative repeat dosing during long surgeries as this is a major cause of antibiotic 
prophylaxis errors. Anderson (20 11) reported that antibiotic therapy should be 
admininistered within 60 minutes prior to the surgical procedure to ensure adequate drug 
tissue levels at the time of surgical incision or 120 minutes if vancomycin or a 
fluoroquinolone is being used. 
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Meeks et al. (20 11) conducted a retrospective chart review in adult patients 
undergoing elective and emergent lapartomies for colorectal procedures abdominal 
hysterectomies, and abdominal vascular procedures. The researchers studied compliance 
with SCIP measures and prevention of SSis. Patients were selected using a randomized 
chart audit, and emergent cases were included due to the increased risk of developing an 
SSI. The study was conducted during two six month periods, July and December 2006 
and July and December 2007. During the timeframe of the study, no specific 
interventions were initiated within the organizations to improve compliance. There were 
51 7 patients included in the study, including 316 abdominal hysterectomies, 189 
colorectal and 14 abdominal, vascular cases. Overall compliance with all three antibiotic 
guidelines only occurred in 62% (274/442) of the cases. While the researchers were able 
to report improvement in compliance with SCIP, they stated that there is room for 
improvement. They reported that the study provided information that can be used to 
develop intervention to help improve compliance (Meeks et al. ). 
In summary, the research supports the appropriate timing and selection of preoperative 
prophylactic antibiotics in preventable surgical site infections. However, the evidence is 
lacking in regard to repeat dosing during surgical procedures lasting greater than four 
hours. In light ofCMS and TJC' s "pay for perfomance" initiatives and public reporting, 
healthcare organizations need to explore the relationship between redosing and the risk of 
developing a SSI. Research is key to prevention. 
Next, the theoretical framework that guided this study will be presented. 
Theoretical Framework 
The Perioperative Patient Focused Model 
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The theoretical framework selected for this research study is the Perioperative Patient 
Focused Model (Rothrock & Smith, 2000). This conceptual framework is used in 
perioperative nursing practice and places the patient and his/her designated support 
person( s) at the core of the model. Concentric circles that extend beyond the patient and 
their support person(s) represent perioperative nursing domains and elements. This 
model is composed of four domains including patient safety, physiologic responses, and 
behavioral responses, and the healthcare system in which perioperative care is provided 
(Appendix C). The choice of this patient focused model is fitting for this research project 
as it centers on the patient and positive outcomes, which is the true focus of perioperative 
nursing. The development of a surgical site infection impacts the patient' s physical and 
behavioral well being, compromises patient safety, and can have major financial impact 
on the healthcare facility. A common complication of surgery, SSI is known to increase 
morbidity and mortality, length of hospital stays, and health care cost (Allen, 2009). This 
nurse-driven model utilizes the perioperative nurse ' s unique knowledge base to care for 
all types of patients and procedures. Using the nursing process, the perioperative nurse 
should perform an individual patient assessment, determine the patient's SSI risk, 
formulate a nursing diagnosis, and select those interventions that will aid in prevention of 
an SSI ("Standards ofPerioperative Nursing," 2011). 
In the next section, the method used in this study will be presented. 
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Methodology 
Purpose/Specific Aims 
The purpose of this study was to evaluate the timely administration, appropriate 
selection, and dosage of preoperative prophylactic antibiotics, and the impact in the 
prevention of surgical site infections. 
Research Question 
The research question was: What impact did the timing and selection of prophylactic 
antibiotics have on preventable surgical site infections. 
Design 
This research study utilized a retrospective design with chart audits (Po lit & Beck, 
2008). 
Site and Sample 
This study was conducted at a community hospital in Rhode Island. The sample 
included patients who underwent surgery at the study site who met the inclusion criteria: 
adults undergoing elective and emergent colon, hysterectomy, hip, and knee arthroplasty. 
This subset was selected because these procedures have specific recommendations from 
SCIP regarding preoperative antibiotic prophylaxis. Exclusion criteria included: less than 
18 years of age; a hospital length of stay greater than 120 days; underwent any procedure 
performed entirely by a laparoscope; a documented infection prior to the surgical 
procedure; any diagnosis suggestive of a preoperative infectious disease; receiving 
antibiotics more than 24 hours prior to surgery (except colon surgery). 
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Procedure 
Permission to conduct this study was obtained from the ChiefNursing Officer, 
Director of Surgical Services, and immediate supervisors. Institutional Review Board 
(IRB) approval was obtained from Rhode Island College and the community hospital ' s 
IRB. After approval, data were collected on surgical cases that occurred between 
October 1, 2010 and March 31 , 2011. The electronic medical record for those patients 
with elective and emergent colon, hysterectomy, hip and knee arthroplasty within the 
designated timeframe were reviewed using data collection sheets supplied by the Quality 
Improvement (QI), Infection Prevention and Control (IPC) departments, and Cemer® 
electronic documentation software at the community hospital. The QI department uses 
the Thompson-Reuters Care Discovery Data Measure software to track those surgical 
procedures that are part of the SCIP initiative. The IPC department at the time of this 
study used a Microsoft Excel® spreadsheet for tracking all reported SSis. 
A target sample of 100 was desired. Based on the surgical volume, this researcher 
collected data on every 3rd surgical procedure that met the inclusion criteria. All records 
were first reviewed for inclusion criteria and if not met, were excluded. Data collected 
were de-identified and stored in a locked file accessible only to the researcher. If any 
data was missing, the patient record was excluded from the study and the data collection 
tool was destroyed. 
Measurement 
After determining eligibility, a data collection tool developed by this researcher was 
used to collect relevant data (Appendix D). Using the subjects' medical record number 
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as the identifier, demographic information was obtained that included sex, age, weight, 
BMI (body mass index), male or female gender, and any co-morbidities. This researcher 
then utilized SCIP data obtained from QI to collect information from the subjects' 
medical record that included the type of surgery/procedure, including surgical start and 
stop times. Risk factors for infection were evaluated including: diabetes/type; smoking 
history; previous infections; infectious disease present ( e.g. MRSA); recent 
hospitalizations; antibiotics administered in the past 24 hours; and oral prophylaxis for 
colon surgery (if applicable). Data related to the timing of prophylactic antibiotics, the 
name/type of antibiotic administered, repeat dosing for surgical procedures greater than 
four hours, and if the patient received preoperative antibiotic prophylaxis were collected. 
Any re-dosing of antibiotic during the surgical procedure was included in the data 
collection only if the patient had received a preoperative prophylactic antibiotic. 
To identify SSI infections from the sample, the IPC provided a list of reported SSis 
during the timeframe of this study. Any data relevant to the infection was also 
documented in this researcher's data collection tool. The data collected from both the QI 
and IPC departments were entered into a Microsoft Excel® database that was created and 
maintained by the researcher. There is no computer software in the hospital that enables 
the QI and IPC departments to correlate their data with respect to SSis and antibiotic 
administration or timing. 
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Timeframe 
Data collection for this study was completed over an 6 month time period. 
Human Subjects Considerations 
This was a retrospective design and thus patient consent was not needed. Data 
collected included the medical record number but only for selection of the correct 
medical record. Once the data collection record was completed for a subject, the medical 
record number was removed. Anonymity and confidentiality was maintained throughout 
the study. Data was collected by the researcher and stored in a locked file that only the 
researcher and faculty advisor had access to. All data collected was destroyed 
immediately upon completion of the study. 
Data Analysis 
Data gathered were entered into an Microsoft Excel® spreadsheet for the purposes of 
organizing patient data. The exact timing of prophylactic antibiotic administration before 
incision and the start of the surgical procedure was calculated in minutes and entered into 
a frequency distribution table. The mean, median, and mode of all the selected surgical 
procedures were determined along with IPC data to correlate the incidence of a 
documented SSI within the tirneframe of this study. 
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Results 
Overall, I 00 medical records were reviewed, with 82 (82%) comprising the sample, 
and 18(18%) records excluded due to incomplete records. The sample included 54 (54%) 
females and 28 (28%) males, and the mean age was 65.42 years with a range of 40-91 
years. 
The sample identified by procedure included: 15 colorectal cases (23.07%); 12 
hysterectomy cases (18.46%), 25 total knee arthroplasty cases (38.46%); and 30 total hip 
arthroplasty cases ( 46.15% ). 
Body mass index (BMI) was calculated to determine the need for weight-adjusted 
dosing in a subset of subjects , those with a BMI greater than 30. The mean BMI for all 
subjects was 25.8. Twenty-two subjects had a BMI of greater than 30, indicating obesity, 
with a mean BMI of36.51. No weight adjusted dosing was detected for any of those 
subjects with a BMI greater than 30. Prophylactic antibiotic dose was administered 0-29 
minutes before surgical incision in 27 cases (32.9%). In another 54 cases (65%), the 
prophylactic antibiotic was given 30-60 minutes before surgical incision. The mean time 
of antibiotic administration was 31.23 minutes. There were two cases in which the 
procedure lasted greater than four hours, with no re-dosing in either case. In more than 
half of the colon (53%) and hysterectomy (58%) procedures, the prophylactic antibiotic 
was administered in a 0-29 minute timeframe, whereas in the total hip (72%) and total 
knee (60%) arthroplasty cases, the antibiotic was given within a 30-60 minute timeframe. 
Compliance with the choice of antibiotic did meet SCIP recommendations in all 
procedures (100%). There was no re-dosing (0%) for colon and hysterectomy procedures 
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that lasted greater than 4 hours, and no (0%) procedure adjusted the dose of antibiotic 
based on weight or BMI. Compliance with SCIP selection of antibiotics by type of 
procedure as well as the timing, and administration of antibiotics are illustrated in 
Table 3. 
Table 3 
Comparison of Antibiotic Compliance with SCIP Guidelines by Case 
N=82 Colo rectal Hysterectomy Total Hip Total Knee 
N=IS N=l2 N=25 N=30 
Compliance with 0-29 minutes 0-29 minutes 0-29 minutes 0-29 minutes 
antibiotic timing N=8 (53%) N=7 (58%) N=7 (28%) N=12 (40%) 
prior to incision 
30-60 minutes 30-60 minutes 30-60 minutes 30-60 minutes 
N=7 (46%) N=5 (42%) N=18 (72%) N=l8 (60%) 
Compliance with N=15 (100%) N= 12 (100 %) N=25 (100%) N=30 (100%) 
antibiotic 1 case received I case received 
selection Vancomycin* Clindamycin* 
Compliance with N=l N=l No procedures No procedures 
re-dosing for Length of Length of 0 4° 0 4° 
procedures 0 4° procedure =4 .23 procedure =4.16 
hours hours 
No re-dosing No re-dosing 
(0%) (0%) 
Weight adjusted No (all cases) No (all cases) No (all cases) No (all cases) 
dosing for BMI ~ (0%) (0%) (0%) (0%) 
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* Vancomycin and Clindamycin alternative antibiotic for patients with PCN allergy 
28 
Table 5 illustrates the sample participants who were identified as having a SSI. 
Overall, this table demonstrates that the selection of antibiotic for those procedures 
resulting in a SSI did meet the SCIP recommendations. The timing of the antibiotic in 
those cases where the administration of the antibiotic is less than 30 minutes prior to 
incision does meet SCIP recommendations, however this is not considered optimal timing 
for adequate tissue perfusion. During this time period, there were eight documented 
SSis, three involving an organ space and five that were superficial. 
Table 5 
Surgical Site Infections October 1, 2010- March 31, 2011 
Infection Administration of Antibiotics SCIP 
Procedure Antibiotic Before Incision 
1 Hip Bipolar Organ space Ancef1 gram < 30 minutes Yes 
2 Colon Resection Superficial Ceftriaxone 2 grams < 30 minutes Yes 
UTO Antibiotic given in Pre- UTO 
3 Colon Resection Superficial Cefotetan 2 grams given 1111 o op 
4 Colon Resection Organ space Cefoxitin 2 grams< r < 1 hour Yes 
5 Colon Resection Superficial Cefoxitin 2 grams after start time < 1 hour Yes 
6 Colon Resection Superficial Mefoxin 2 grams <1 ° < 30 minutes Yes 
7 Colon Resection Superficial Cefoxitan 1 gram <1 ° < 30 minutes Yes 
8 Colon Resection Cefoxitan 2 < 30 minutes Yes 
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Summary and Conclusions 
In summary, this study evaluated the timely administration, appropriate selection, and 
dosage of preoperative prophylactic antibiotic in surgical patients. A retrospective 
research design was used to obtain data from 100 randomly selected colon, hysterectomy, 
total hip and total knee arthroplasty cases. These cases were then evaluated for the 
presence of a SSI. In more than half of the colon and hysterectomy cases, it was found 
that the prophylactic antibiotic was administered less than 30 minutes before surgical 
incision, and in more than half of the total hip and total knee arthroplasty cases, the 
antibiotic was administered in the 30-60 minute timeframe. The timeframe allows for 
adequate tissue perfusion as recommended in much of the literature. All the procedures 
met the SCIP recommendations for timing and selection of prophylactic antibiotic; 
however the evidence does support that adherence to the SCIP guidelines is necessary to 
reduce the risk of a SSI. The incidence of infection while relatively small does support 
the need for further investigation with regard to the timing of the prophylactic antibiotic 
and the need for prevention of further SSis. 
There were some limitations encountered while conducting this study. This researcher 
experienced difficulty locating specific subject data due to a hybrid charting system 
within the community hospital. The anesthesia record is completely on paper while the 
nursing documentation is all electronic. There was a portion of study data that had to be 
excluded due to incomplete documentation of the timing, selection, and dosage of 
prophylactic antibiotic. Secondly, the QI and IPC departments do not have software 
programs that communicate relevant data with regards to SCIP measures and patient 
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infections. Both operating systems function independently, making correlation of data 
very time consuming. Lastly, the IPC department tracks those surgical infections 
reported by the surgeons or when a surgical patient is readmitted to the hospital. The 
accuracy with which a SSI is reported cannot always be determined and in most 
situations is based solely on notification from the surgeon. 
Based on the fmdings of this study, it can be concluded that these practices were 
consistent with the guidelines. The timing of the preoperative prophylactic antibiotic did 
meet the SCIP guidelines of administration within one hour before surgical incision. 
However, the evidence clearly supports administration of the antibiotic within the optimal 
timeframe of between 30-60 minutes for adequate tissue perfusion and for prevention of a 
SSI. In all cases of a SSI, the selection of antibiotic were ones identified from the SCIP 
recommended list of antibiotics. There-dosing of the antibiotic for procedures lasting 
greater than four hours did not occur in all the surgical cases, and weight adjusted 
dosing did not occur despite the significant number of patients identified as obese. 
Improvements can be made with regards to the timing and administration of preoperative 
prophylactic antibiotic. A recommendation will be made to the community hospital's 
Anesthesia and Surgical Department proposing that the prophylactic antibiotic be hung 
via IV in the preoperative holding unit and immediately prior to transfer to the operating 
room the antibiotic would be started. This would ensure that the preoperative 
prophylactic antibiotic is given within the 30-60 minute timeframe, thus reducing the 
potential for the development of a SSI and improving patient outcomes. 
31 
Recommendations and Implications 
One of the primary roles of the Advanced Practice Registered Nurse (APRN) is to 
improve the quality of patient care. This researcher identified a quality improvement 
opportunity that had the potential to improve patient safety and outcomes and enhance 
the clinical competence of the surgical team. Assuming the role of the APRN, this 
researcher proposes to develop a protocol for daily patient rounding on surgical units for 
the purpose of monitoring adherence to SCIP measures. Further education is needed for 
surgeons and peri operative staff regarding the common causes of SSis and preventive 
measures that must be taken to prevent a SSI. Patients and their families should receive 
education prior to surgery regarding the definition of SSis and what the patient can do to 
prevent an incidence. APRN leadership in furthering collaboration with the Anesthesia 
Department is needed to develop a protocol for initiating the prophylactic antibiotic in the 
pre-operative unit. This protocol would ensure that the timing of the antibiotic is within 
an optimal timeframe and that adequate tissue perfusion would occur. 
In the study facility, it was primarily the Department of Anesthesia that administered 
the preoperative prophylactic antibiotics. The evidence supporting the administration of 
the prophylactic antibiotic within a 30-60 minute timeframe, as well as the results of this 
study, will be shared with the Anesthesia Department, Surgical Services Department, IPC 
and QI Departments. Recommendations for change will be discussed and extensive 
education and training must be provided to staff in all departments of Surgical Services to 
make this initiative successful. This quality practice change has the potential to improve 
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patient outcomes by reducing the risk of developing a SSI and thus reduce any costs 
incurred to the hospital for the treatment of a SSI. 
The APRN is instrumental in identifying further questions for clinical research. This 
study demonstrates the need for further research with regards to weight-adjusted dosing 
of prophylactic antibiotic for the bariatric patient population. On-going monitoring for 
implementation of best evidence-based interventions and evaluation of patient outcomes 
are key activities of the CNS. 
Challenges in detecting and preventing SSis continue to be problematic for healthcare 
facilities. Several organizations both national and international have collaborated to 
develop guidelines for the prevention of a SSI and other types of HAL For example, The 
World Health Organization (WHO) developed a publication entitled Prevention of 
hospital-acquired infections: A practical guide (2002) which discussed HAl, the etiology, 
as well as prevention strategies. The CDC has developed the National Healthcare Safety 
Network (NHSN), an Internet based surveillance system which facilities can use to 
monitor the rates of SSI as well as to submit data related to HAis as mandated by their 
specific state legislation (www.cdc.gov). TJC has included SSis as a National Patient 
Safety Goal (NPSG- Goal 7 _07 .05 .001) and expects that healthcare facilities will 
perform targeted surveillance for SSis for those procedures considered to be high risk for 
SSI. TJC also created the Surgical Site Infection Project with the aim of reducing SSis 
in patients with colorectal surgery and procedures. The project is a collaboration that 
includes the American College of Surgeons (ACS), and it is utilizing the National Quality 
Improvement Program (NSQIP) for surgical outcome data collection and analysis. This 
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effort is being undertaken to determine specific risk points and contributing factors 
related to SSis and the aim is to then develop and implement solutions for the prevention 
of SSis. The Society for Healthcare Epidemiology of America (SHEA) and Infectious 
Diseases Society of America (IDSA) have published the Compendium of Strategies to 
Prevent Healthcare-Associated Infections in Acute Care Hospitals 
(www.thejointcommisssion.org) that includes evidence-based practice information for 
acute care hospitals for the prevention HAis. This document is a culmination of 
recommendations by those organizations that are considered champions in infection 
prevention: SHEA;IDSA; American Hospital Association (AHA); APIC; and TJC. The 
Institute For Healthcare Improvement (IHI), a not-for-profit organization that is 
instrumental in leading healthcare improvement, has issued a publication entitled: How-to 
Guide: Prevent Surgical Site Infections which identifies four components of care that are 
recommended by the IHI for the prevention of SSis. The goal of all of these 
organizations is prevention of SSis and to increase overall patient safety and healthcare 
quality. US health care policy must continue to emphasize, support, and promote 
healthcare quality. 
Any improvement process related to the prevention of SSis must be driven by the 
leadership within the healthcare organization. Involvement of a multidisciplinary team is 
essential in a SSI improvement project. This team should meet regularly to examine 
performance on antibiotic administration as well as the other SCIP measures, review 
pertinent hospital data, implement changes for improvement, and review the results. 
Process and system changes need to occur within the healthcare organization to improve 
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administration of prophylactic antibiotics. The development and use of both electronic 
and paper standing orders that include the specifics related to the antibiotic timing, dose, 
and discontinuance is necessary for compliance The possible development of a 
pharmacist and/or nurse driven protocol that would include the type of antibiotic 
selection and dose and all based on SCIP guidelines should be considered. The 
responsibility for the dosing of the antibiotic should be assigned to either anesthesia or a 
designated nurse to improve the timeliness. A visible reminder or checklist to remind 
staff to give an antibiotic could be developed and implemented in the preoperative areas. 
The involvement of pharmacy, infection control and nursing should occur to ensure that 
the prophylactic antibiotics are selected and given in a timely manner. The CNS is 
trained and well prepared to assume a leadership role within the inter-disciplinary team to 
assure that high quality care remains an institutional priority. 
35 
Appendix A CMS Core Measure SCIP: Surgical Care Improvement Project 
~~1'CMS CORE MEASURE~'£·~,>:~· ·· 
SCIP: SURGICAL CARE,IMPR.OVEMENT PROJECT 
SCIP IS a nattOnal quality partnership of organ~zat1ons focused on reducmg the mcidence of surg1cal comphcattons. 
t . PROPHYLACTIC ANTIBIOTIC PREOP TIMING · 
Pfeoptr~~t;w prophytactic antibiotic to bll!l administered wtl'hin one hour prior to ircision. 
• • 2 hcus 'for ~n « FkKxoquinotone.s 
2. PROPHYLACTIC ANTIBIOTIC SELECTION ~ • ~ :._1_• .... 
CMS REQUIREMENTS FOR INPATIENTS 
CABG,Oiht:rCilldg£ot 
-
--
-
_.,.__, 
a-
~ ... ~il\. 
-
u-. 
00""--a 
~·~ 
CMS REQUIREMENTS FOR OUTPATIENTS 
--
--
-
--
-
-
.___ 
lM;u .,.,... 
--
-
-
t'.d-* "'~Q:foMinQI' 
~Uf~Uf 
Cal~cw~• 
-
....._ 
C.2""~~ 
•:r~~ 
--· 
-~· """"--  ................ 
-~·~ 
-a r~~t~<
_._ 
-~ .. , .. ~ 
-~· ~ Qtlltl.~ 
-~'~ - ·.. -... 
, .. (;ewer..,.~ 
........... 
1.-i~~ 
-~·~ -  .. 
·-~~ .,....~~ 
-.. ..__ 
~·~or 
~·~or 
--·-·~·~ .,~.o.---
~·~f'O 
-  .. Orliw---~--~ OIII • Ouifdorle 
~,._ .... ~ 
-Ala~+~ 
-~+~ 
-~·~ 
 ... ~
-~·Owildone 
-~·~· 
- (l!lldMn,odn ..  
OII +Ouin!:llone 
· 3. PROPHYLACTIC ANTIBIOTIC DISCONTINUATION WITHIN 24 HOURS (48 
. HOURS FOR CV SURGERY) AFTER SURGICAL END TIME 
Ad<nitlisrml'ion of anbbiotic:s lor more lhlrl24 hnl)rs after 1he incision is' clo:wd. otffts no •lf.ititlmf 
benefit to1he ~ pat:ieN. ~ lllBlUIRED FOIITMEMPIITK:~ 
4 CARDIAC S URGERYPATIENTS WITH CONTROllED 6 JLM. 
POSTOPERATIVE BlOOD GLUCOSE POSTOPERATIVE DAY 1 AND DAY 2 
Hypergtycemia has been ass:oci<rtad with increased in-ho!lpi.tal morbidity lkld monlllity tor-~ 
medical am .sugK:a~ conditiam. Once identified.~ eoutcs minirniza ~ outcomes ror 
catdiac surgical patients.. 
• 5)!AIR.~EMOVAl ' • • 
6 . TEMPERATURE MANAGEMENT WITH IMMEDIATE POSTOPERATtVE 
NORMOTHERMIIt ·•. . 
l~ature must be ~ to or greater than 96..8* f within J:IJ mirdes priof 10 ~a end rime Of 
knmW"Iltlety 15 minutes after ane..s'lhesia erd rime. 
Exduded: P<Jtients with~ int81'1liooat hypothermia.. 
Palient.s 011 Beta-Biodrer should recefw their Betn-Biocbr r-lor 1n atJival or lbing the ~live 
period fwithin 2o\ hotn fJf ~OJ disdtarge rrnm PI\CUJ. 
r 8. VENOUS fHROMSOEMBOLISM fVTE ) PROPHYLAXIS •, h.::, C0:1 f,yn~ul 
VTE prophylaais orderedar1\'time from hosf)i'lal arrival to 2.e hOt.n aher ~end time. 
VTF prophylaxis lece#vedwitNn 24 hotn priot to~ klti5ic:ln time ToZ4 hours afH!I" 
.$U'Q181'Yendtime. 
SURGERY "TYPE RECOIIMENDED PftOPHYI..ACTJC OPTIONS 
--
.,. __ 
Hip~Swge" ....... , _ . FicMiw;-
~~ 
.... ..., ... ,.,.,.. 
.. .....,._,..praXNU:~~.-cl~arwi'lt1ool~ 
~~(OCSJ 
•low-dcM~~lDI.H 
• t"""...-...we:SPfot~{U.IIMiJ 
• l.Ol.ltt~tl.UIM-lcurdlired ....... I'C ce" GCS 
IJert"l lfrf<+wm 
· I.Dw-r:ID.e~,__ .. DtH 
· I.Dw~blpw.tft Q..l.M-1-0 
• t.Dl.HotUI!Mic:nbn..s"'•IJ'CorGCS 
t.nva· ~  
· 6r:ac:lwlcd~~t6131 
.. ~pna,-=c~di!Ma!s~ 
AtJvdrtr ............ 
·u.-o:sa~~A.IUO 
• W.mdecr.ll¥~~n flM'o\1-ij 
- ~~CD'fflf---....,;>Q 
•1 0ll-l<7lM'I\,.. _.....,_..n:w~ 
Apc<1#r! ......... 
· l.ow-dl:lle~~tw..(l 
.. ~~----lrlftlannll.MWHJ 
· ~twnonetJII'IlOC~~If'O 
-~~~fOCS) 
-~OI'I.MNH~widtlf'CttrGCS 
te« oltl!r:.........,....,.,lM!!t.n?1Mo ct ....,.... 
• l.owndealllr_.,..~~ 
• f.lltlarXaw.llrtor~ 
-,_,.,, .. ,........... 
-~~~oe.otcetllf'Q 
.. ..,.,.._fllo:lt~Ml'J 
IWY•'1r ........... 
-~~ ....... Ulll4) 
• lDIOi mnll!~••r~.._..,llMA'Hl 
- ~xaWliillm:Jr~ 
·-~ 
AnQf1rfrA!rrrR 
• ("......_.,~~F"oCil 
.. ....... ~~~do!Mc:aii?Q 
· ~foocf!U'CIMP'I 
Amfilfr,..,...., 
• 1..- lldealar-..gN '-"' fi,MWt-fl 
· •adtlf'X.Wititi:r~ 
9. URINARY CATHETER REMOVAl ~ POD 1 or POD 2 
Urinery calhotet rm JDYed on po3t-opetllliYe day l OJ 21d.Y( ol SUIVt"Ybeinv Pa Ol. 
Excluded: Patients Yllhc had a urologi!::at, gynecoklgit:31 OJ perineal operation: ore~ ~ian 
docu'nerttation ftw reason na1 to rernow.. 
Appendix B Prophylactic Antibiotic Regimen Selection for Surgery 
SCIP - Inf-2-5 
Specifications Manual for National Hospital Inpatient Quality Measures 
04-01-2011-12-31-2011 
Surgical Procedure Approved Antibiotics 
CABG,other Cardiac or Cefazolin,Cefuroxime,or Vancomycin. If fl-lactam 
Vascular allergy: Vancomycin or Clindamycin 
Hip/Knee Arthroplasty Cefazolin,Cefuroxime,or Vancomycin. If fl-lactam 
allergy: Vancomycin or Clindamycin 
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Colon Cefotetan,Cefoxitin,Ampicillin/Sulbactam or Ertapenem OR 
Cefazolin,or Cefuroxime+Metronidazole.IF fl-lactam 
allergy:Clindamycin+ Aminoglycoside or 
Clindamycin=Quinolone or Clindamycin+Aztreonam OR 
Metronidazole with Aminoglycoside or Metronidazole 
+Quinolone 
Hysterectomy Cefetetan,Cefazolin,Cefoxitin,Cefuroxime or 
Ampicillin/Sulbactam.lf fl-lactam allergy: 
Clindamycin+Aminoglycoside, Clindamycin=Quinolone, 
Clindamycin+Aztreonam OR Metronidazole with 
Aminoglycoside or Metronidazole +Quinolone 
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Appendix C Perioperative Patient Focused Model 
Perioperative Patient Focused Model© 
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Appendix D Data Collection Tool 
Data Collection Tool 
~Studyolthel...-:iol Plaplalytic Alllilliatics in the~ol Sullliml Site IIIIa: Iions 
Medal Remrd fbrlber: 
Pdellt Dmi!Jta~ 
~ Height w~ lbs BMI M~en Female o 
iswlblhilaiMti»n 
!Tvpe of Surgery: Colon __ Hysterectomy __ Hip Arthroplasty __ Knee Arthroplasty __ 
Name of proredure: 
Pro~dure performed bv Laparascope? Yes lJ Now 
St.rgical Start Tine(incision made) 
End a st.rgerv 
Rilkr.tcn 
History .of Diab!!es: YesD Type: NoD 
Smoker: Ye;D No w 
Previous lnfectm? Yesr:: NoD 
Infectious disease preserw:? Y esc Nane ___ NoD 
Rec:erl ha;ptaizaion 2120 days? Ye;D No= 
Artl:licxics> 24 hot.rs? Yeso NoD T~ Howkq 
O~ pr~acti:for cobnsu-gffY? Yes o No n T~ 
.... <"'-" 
· Me&iiidi.tiun I 
Tme Proptlflcr::tic:Art.biexi:: Amfni!naion 
Artl:licxic Mni'list:raion Before lncisbn : o-29 mi'Ues 
---
30-60 m·rues __ 
~ypey'Oosage of Prophylcr::tic Annli>ti:: Administered 
Surg~ Procedxe > 4 hOLrs? Yes D NoD 
Repeat dose of antl:liexk given? Yeso No= 
Cathy S nsc.1a, BSN, RN ,CNOR 
CSI 9/2011 
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